Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody; IND# 100947; NSC# 742460) in Children with Relapsed/Refractory Solid Tumors: A COG Groupwide Phase II StudyCIRB: Pediatric CIRBLead Group: COGStatus: CompletedReview Status: Completed
